PARMAR, A.; TIMILSHINA, N.; EMMENEGGER, U.; SMORAGIEWICZ, M.; SANDER, B.; ALIBHAI, S. .; CHAN, K. K. A cost-utility analysis of apalutamide for metastatic castrationsensitive prostate cancer. Canadian Urological Association Journal, [S. l.], v. 16, n. 3, p. E126–31, 2021. DOI: 10.5489/cuaj.7495. Disponível em: https://cuaj.ca/index.php/journal/article/view/7495. Acesso em: 26 apr. 2024.